I would also note the use of multiple as in " we advance NNZ-2591 in multiple indications for global markets" . Hopefully this indicates we are progressing the other indications and not awaiting the PMD trial outcome. How capable is the company of commencing/progressing multiple phase 3 trials simultaneously?
NEU Price at posting:
$12.52 Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)